Literature DB >> 10408392

A quantitative analysis of the reduction in oxygen levels required to induce up-regulation of vascular endothelial growth factor (VEGF) mRNA in cervical cancer cell lines.

J A Chiarotto1, R P Hill.   

Abstract

The presence of hypoxia (low oxygen concentrations) in solid tumours correlates with poor prognosis, increased metastasis, and resistance to radiotherapy and some forms of chemotherapy. Malignant cells produce an angiogenesis factor, vascular endothelial growth factor (VEGF), which may increase metastatic ability and is up-regulated in the presence of hypoxia. Clinical data for cancers of the cervix and head and neck relate oxygen levels in the tumour to treatment outcome. This suggests the possibility that the presence of VEGF mRNA might be used as a marker for relevant levels of hypoxia. Suspension cultures of three human cervical cancer cell lines, SiHa, ME-180 and HeLa, were used to investigate up-regulation of VEGF mRNA levels following exposure to precisely defined oxygen concentrations for 2 or 4 h. An oxygen sensor was used to confirm the actual levels of dissolved oxygen present. The oxygen concentrations which caused half-maximal upregulation (the Km value) of VEGF mRNA level in the three cell lines were similar except for one instance (Km at 4 h: SiHa 27.0 +/- 5.7 microM, ME-180 16.8 +/- 3.3 microM, HeLa 13.0 +/- 1.8 microM, SiHa and HeLa P = 0.01). The Km values for the HeLa cell line as measured at 2 h (24.9 +/- 0.8 microM) and 4 h (13.0 +/- 1.8 microM) were significantly different (P < 0.0001). VEGF mRNA half-lives measured in air were consistent with values in the literature (SiHa 59.8 +/- 5.8 min, ME-180 44.4 +/- 7.2 min, HeLa 44.5 +/- 6.3 min). Differences in oxygen consumption at low oxygen concentrations were noted between the different cell lines. Stirring in suspension culture was found to induce VEGF mRNA in SiHa cells. The presence of VEGF mRNA may be a marker for radiobiologic hypoxia.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10408392      PMCID: PMC2363165          DOI: 10.1038/sj.bjc.6690555

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  49 in total

1.  Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy.

Authors:  R A Gatenby; H B Kessler; J S Rosenblum; L R Coia; P J Moldofsky; W H Hartz; G J Broder
Journal:  Int J Radiat Oncol Biol Phys       Date:  1988-05       Impact factor: 7.038

2.  An examination of the effects of hypoxia, acidosis, and glucose starvation on the expression of metastasis-associated genes in murine tumor cells.

Authors:  A Jang; R P Hill
Journal:  Clin Exp Metastasis       Date:  1997-09       Impact factor: 5.150

3.  Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck.

Authors:  M Nordsmark; M Overgaard; J Overgaard
Journal:  Radiother Oncol       Date:  1996-10       Impact factor: 6.280

4.  A thin-film culturing technique allowing rapid gas-liquid equilibration (6 sec) with no toxicity to mammalian cells.

Authors:  C J Koch
Journal:  Radiat Res       Date:  1984-02       Impact factor: 2.841

5.  Hypoxia and vascular endothelial growth factor expression in human squamous cell carcinomas using pimonidazole as a hypoxia marker.

Authors:  J A Raleigh; D P Calkins-Adams; L H Rinker; C A Ballenger; M C Weissler; W C Fowler; D B Novotny; M A Varia
Journal:  Cancer Res       Date:  1998-09-01       Impact factor: 12.701

Review 6.  Oxygen sensing and molecular adaptation to hypoxia.

Authors:  H F Bunn; R O Poyton
Journal:  Physiol Rev       Date:  1996-07       Impact factor: 37.312

Review 7.  The unique physiology of solid tumors: opportunities (and problems) for cancer therapy.

Authors:  J M Brown; A J Giaccia
Journal:  Cancer Res       Date:  1998-04-01       Impact factor: 12.701

8.  Significance of vascular endothelial growth factor/vascular permeability factor for solid tumor growth, and its inhibition by the antibody.

Authors:  S Kondo; M Asano; H Suzuki
Journal:  Biochem Biophys Res Commun       Date:  1993-08-16       Impact factor: 3.575

9.  Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix.

Authors:  M Höckel; C Knoop; K Schlenger; B Vorndran; E Baussmann; M Mitze; P G Knapstein; P Vaupel
Journal:  Radiother Oncol       Date:  1993-01       Impact factor: 6.280

10.  Enhanced expression of vascular endothelial growth factor in metastatic melanoma.

Authors:  P Salven; P Heikkilä; H Joensuu
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

View more
  11 in total

1.  Differences of vascular endothelial growth factor (VEGF) expression between liver and abdominal metastases from colon cancer. Implications for the treatment with VEGF inhibitors.

Authors:  S Cascinu; F Graziano; V Catalano; M P Staccioli; S Barni; P Giordani; M C Rossi; A M Baldelli; P Muretto; A Valenti; G Catalano
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

2.  Hypoxia-activated cytotoxic agent tirapazamine enhances hepatic artery ligation-induced killing of liver tumor in HBx transgenic mice.

Authors:  Wei-Hsiang Lin; Shiou-Hwei Yeh; Kun-Huei Yeh; Kai-Wei Chen; Ya-Wen Cheng; Tung-Hung Su; Ping Jao; Lin-Chun Ni; Pei-Jer Chen; Ding-Shinn Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-04       Impact factor: 11.205

3.  Comparison of molecular markers of hypoxia and imaging with (60)Cu-ATSM in cancer of the uterine cervix.

Authors:  Perry W Grigsby; Robert S Malyapa; Ryuji Higashikubo; Julie K Schwarz; Michael J Welch; Phyllis C Huettner; Farrokh Dehdashti
Journal:  Mol Imaging Biol       Date:  2007 Sep-Oct       Impact factor: 3.488

4.  Tissue uptake of BSH in patients with glioblastoma in the EORTC 11961 phase I BNCT trial.

Authors:  Katalin Hideghéty; Wolfgang Sauerwein; Andrea Wittig; Claudia Götz; Philippe Paquis; Frank Grochulla; Klaus Haselsberger; John Wolbers; Ray Moss; Rene Huiskamp; Heinz Fankhauser; Martin de Vries; Detlef Gabel
Journal:  J Neurooncol       Date:  2003 Mar-Apr       Impact factor: 4.130

5.  Down-regulation of Rad51 and decreased homologous recombination in hypoxic cancer cells.

Authors:  Ranjit S Bindra; Paul J Schaffer; Alice Meng; Jennifer Woo; Kårstein Måseide; Matt E Roth; Paul Lizardi; David W Hedley; Robert G Bristow; Peter M Glazer
Journal:  Mol Cell Biol       Date:  2004-10       Impact factor: 4.272

6.  Graded hypoxia modulates the invasive potential of HT1080 fibrosarcoma and MDA MB231 carcinoma cells.

Authors:  Patrick Subarsky; Richard P Hill
Journal:  Clin Exp Metastasis       Date:  2008-01-10       Impact factor: 5.150

7.  Assessment of hypoxia inducible factor levels in cancer cell lines upon hypoxic induction using a novel reporter construct.

Authors:  Wenyu Zhou; Timothy L Dosey; Travis Biechele; Randall T Moon; Marshall S Horwitz; Hannele Ruohola-Baker
Journal:  PLoS One       Date:  2011-11-23       Impact factor: 3.240

8.  Evidence that involucrin, a marker for differentiation, is oxygen regulated in human squamous cell carcinomas.

Authors:  S-C Chou; Y Azuma; M A Varia; J A Raleigh
Journal:  Br J Cancer       Date:  2004-02-09       Impact factor: 7.640

9.  The constitutive level of vascular endothelial growth factor (VEGF) is more important than hypoxia-induced VEGF up-regulation in the angiogenesis of human melanoma xenografts.

Authors:  T Danielsen; E K Rofstad
Journal:  Br J Cancer       Date:  2000-05       Impact factor: 7.640

10.  Vascular endothelial growth factor (VEGF) expression is a prognostic factor for radiotherapy outcome in advanced carcinoma of the cervix.

Authors:  J A Loncaster; R A Cooper; J P Logue; S E Davidson; R D Hunter; C M West
Journal:  Br J Cancer       Date:  2000-09       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.